ARROWHEAD PHARMACEUTICALS, INC. Quarterly Other Assets, Current in USD from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly Other Assets, Current history and growth rate from Q3 2013 to Q3 2024.
  • Arrowhead Pharmaceuticals, Inc. Other Assets, Current for the quarter ending September 30, 2024 was $4.97M, a 23.3% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.97M +$940K +23.3% Sep 30, 2024 10-K 2024-11-26
Q2 2024 $4.18M -$2.98M -41.6% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $7.51M -$6.92M -48% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $7.1M -$18.1M -71.8% Dec 31, 2023 10-Q 2024-02-06
Q3 2023 $4.03M -$16.2M -80% Sep 30, 2023 10-K 2024-11-26
Q2 2023 $7.16M -$1.73M -19.5% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $14.4M +$6.64M +85.2% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 $25.2M +$22.4M +801% Dec 31, 2022 10-Q 2023-02-06
Q3 2022 $20.2M +$18M +822% Sep 30, 2022 10-K 2023-11-29
Q2 2022 $8.89M +$7.2M +424% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $7.8M +$5.95M +323% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $2.8M +$477K +20.6% Dec 31, 2021 10-Q 2022-02-02
Q3 2021 $2.19M +$409K +23% Sep 30, 2021 10-K 2022-11-28
Q2 2021 $1.7M -$716K -29.7% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $1.85M -$691K -27.3% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $2.32M +$784K +51.1% Dec 31, 2020 10-Q 2021-02-04
Q3 2020 $1.78M -$781K -30.5% Sep 30, 2020 10-K 2021-11-22
Q2 2020 $2.41M +$920K +61.6% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $2.54M +$946K +59.5% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $1.53M +$1.06M +221% Dec 31, 2019 10-Q 2020-02-05
Q3 2019 $2.56M +$1.92M +300% Sep 30, 2019 10-K 2020-11-23
Q2 2019 $1.49M +$1.21M +435% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 $1.59M +$1.23M +344% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $478K -$1.13M -70.2% Dec 31, 2018 10-Q 2019-02-07
Q3 2018 $640K -$720K -52.9% Sep 30, 2018 10-K 2019-11-25
Q2 2018 $279K -$617K -68.9% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $358K -$1.39M -79.5% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $1.6M -$1.89M -54.1% Dec 31, 2017 10-Q 2018-02-09
Q3 2017 $1.36M -$2.41M -63.9% Sep 30, 2017 10-K 2018-12-11
Q2 2017 $896K -$611K -40.6% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 $1.75M +$838K +92.2% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $3.5M +$1.59M +83.6% Dec 31, 2016 10-Q 2017-02-06
Q3 2016 $3.77M +$2.95M +358% Sep 30, 2016 10-K 2017-12-12
Q2 2016 $1.51M +$853K +130% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $910K +$582K +178% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $1.9M +$1.84M +2930% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 $824K +$775K +1598% Sep 30, 2015 10-K 2016-12-14
Q2 2015 $655K +$116K +21.6% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 $327K -$306K -48.3% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 $62.8K Dec 31, 2014 10-Q 2015-02-09
Q3 2014 $48.5K -$43.2K -47.1% Sep 30, 2014 10-K 2015-12-14
Q2 2014 $539K Jun 30, 2014 10-Q 2014-08-12
Q1 2014 $634K Mar 31, 2014 10-Q 2014-05-06
Q3 2013 $91.7K Sep 30, 2013 10-K 2014-11-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.